Harbour Investments’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
VCM
VPM
Harbour Investments's EW Position: Q1 2026 in Review
Harbour Investments increased its Edwards Lifesciences (EW) stake by 116% in Q1 2026, buying an estimated $277K and bringing the position to 6,273 shares worth $502K. The position accounts for 0.01% of the portfolio, ranked #1055.
Harbour Investments first reported a position in EW in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.14M in Q2 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Harbour Investments held 6,273 shares of Edwards Lifesciences worth $502K as of Q1 2026.
- Harbour Investments bought 3,365 Edwards Lifesciences shares in Q1 2026, an estimated $277K.
- Edwards Lifesciences made up 0.01% of Harbour Investments's portfolio in Q1 2026, its #1055 holding.
- Harbour Investments first reported a position in Edwards Lifesciences in Q1 2021 and has held it in 20 quarters since.
- Harbour Investments's Edwards Lifesciences position peaked at $1.14M in Q2 2021.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.